Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

Synermore Biologics (Suzhou) Co., Ltd. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
exposureprophylaxisrabiessingle
rabies post-exposure prophylaxis, rabies, single-dog multiple-bite incidents, grade iii rabies exposures, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 994146
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.